FORT WORTH, TX, Agoosto 2, 2022 (GLOBE NEWSWIRE) - TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) waa shirkad heer caalami ah oo caafimaad oo ku takhasustay qaboojiyaha filimka khafiifka ah (TFF) madal tignoolajiyada horumarinta iyo ganacsiga ee alaabada dawooyinka hal-abuurka leh. , maanta waxay ku dhawaaqday inay sii deyn doonto rubuci labaad ee natiijooyinka maaliyadeed ee 2022 iyo dib u eegista ganacsiga Khamiista.Agoosto 11, 2022, marka uu xidhmo suuqyada maaliyadeed ee Maraykanka.
Maareyntu waxay qaban doontaa wicitaan shir 4:30 galabnimo ET si ay uga doodaan natiijooyinka maaliyadeed oo ay u bixiyaan warar ku saabsan horumarka shirkadda iyo caafimaadka.Bandhiga waxaa ku xigi doona kulan Q&A oo lala yeelanayo maalgashadayaasha.
Shirkaddu waxay qaban doontaa wicitaan shir Khamiista, Agoosto 11, 2022 saacadu markay tahay 4:30 galabnimo ET si ay dib ugu eegis ugu sameyso waxqabadka bukaan-socodyada, shirkadda iyo dhaqaalaha.Si aad ugu biirto shirka, ku biir webcast-ka ama garaac mid ka mid ah kuwan soo socda ka hor inta aanad wicitaanka bilaabin:
Wicitaanku wuxuu sidoo kale noqon doonaa mid toos ah oo si toos ah looga heli karo TFF Pharmaceuticals' Website, https://tffpharma.com ama si toos ah https://viavid.webcasts.com/starthere.jsp?ei=1558913&tp_key=43b9453c47. Wicitaanku wuxuu sidoo kale noqon doonaa mid toos ah oo si toos ah looga heli karo TFF Pharmaceuticals' Website, https://tffpharma.com ama si toos ah https://viavid.webcasts.com/starthere.jsp?ei=1558913&tp_key=43b9453c47. Конференция также будет прислироваться в прямом эфире iyo DOSTUPNA на веб-сйте TFF Pharmaceuticals https://tffpharma.com . casts.com/starthere.jsp?ei=1558913&tp_key=43b9453c47. Shirku waxa kale oo si toos ah loo daadihin doonaa oo laga heli karaa website-ka TFF Pharmaceuticals https://tffpharma.com ama si toos ah https://viavid.webcasts.com/starthere.jsp?ei=1558913&tp_key=43b9453c47.电话会议还将进行网络直播，可以在TFF Pharmaceuticals 的网站https://tffpharma.com 3b9453c47 访问. TFF Pharmaceuticals 的网站https://tffpharma.com 或直接访问https://viavid.webcasts.com/starthere.jsp?ei=1558913&tp_key34=43 Конференц-связь также будет транслироваться в Интернете и доступна https://viavid.webcasts.com/starthere.jsp?ei=1558913&tp_key=43b9453c47. Wicitaanku waxa kale oo uu noqon doonaa mareegta oo laga heli karo website-ka TFF Pharmaceuticals ee https://tffpharma.com ama si toos ah https://viavid.webcasts.com/starthere.jsp?ei=1558913&tp_key=43b9453c47.Fadlan booqo bogga shirkadda ugu yaraan 15 daqiiqo ka hor ballantaada si aad isu diwaangeliso, u soo dejiso una rakibto dhammaan software-ka maqalka ah ee loo baahan yahay.Wicitaanku waxa kale oo lagu ciyaari doonaa bisha oo dhan qaybta kalandarka maalgashiga ee mareegaha shirkadda.
Ku saabsan TFF PHARMACEUTICALS Filimka khafiifka ah ee qaboojinta tignoolajiyada Platform TFF Farmashiyaha 'tiknoolajiyada qaboojinta khafiifka ah ee khafiifka ah (TFF) ayaa u oggolaanaysa xeryahooda jira iyo kiimikooyinka cusub in loo beddelo qaabab budo qalalan oo leh astaamo iyo faa'iidooyin gaar ah.Habka qaboojinta filimku waa habka injineernimada qayb loogu talagalay in lagu soo saaro qaybo budada qalalan oo leh sifooyin wanaagsan oo loogu talagalay neefsashada, parenteral, sanka, afka, dariiqyada indhaha iyo indhaha ee maamulka.Nidaamkan waxaa loo isticmaali karaa in lagu horumariyo budada si toos ah loogu geeyo goobta la rabo, si looga fogaado dhibaatooyinka maamulka nidaamka iyo hagaajinta bioavailability, bilawga degdega ah, iyo hagaajinta badbaadada iyo waxtarka.Awoodda daaweynta tooska ah ee loogu talagalay xubnaha bartilmaameedka ah sida sanbabada ayaa u oggolaanaysa budada TFF in lagu maamulo qiyaaso hoose marka loo eego qaababka afka, yaraynta sunta aan loo baahnayn iyo waxyeellooyinka.Xogta shaybaadhka ayaa tilmaamaysa in sifooyinka hawada ee budada la qaboojiyey ee khafiifka ah ay gaarsiin karaan ilaa 75% qiyaasta qoto dheer ee sambabada.Halkii ay ka soo gaadhi lahaayeen kulaylka, diiqada xiirid, ama xoogag kale oo dhaawici kara qaybo badan oo daaweyneed oo adag sida bayoloji jilicsan, baraf khafiif ah ayaa u oggolaanaya alaabtan in loo beddelo budo qallalan oo ay fududahay in la kaydiyo heerkulkuna deggan yahay, taas oo u oggolaanaysa daaweynta iyo tallaalada. in si caalami ah loo qaybiyo..Faa'iidooyinka qaboojinta filimka khafiifka ah waxaa loo isticmaali karaa si loo hagaajiyo bixinta dhaqameed ama lagu daro dawooyinka jiilka soo socda.
KU SAABSAN TFF Pharmaceuticals TFF Pharmaceuticals, Inc. waa shirkad heer-caafimaad biopharmaceutical ah oo adeegsata tignoolajiyada qaboojinta degdega ah ee patented si loo horumariyo oo loogu beddelo dawooyinka qaab-dhismeedka budada qalalan ee waxtarka leh si loo hagaajiyo waxtarka, badbaadada iyo xasilloonida.Shirkadda tignoolajiyada ee kala duwan ee qaboojinta filimaanta khafiifka ah (TFF) waxay leedahay codsi ballaadhan waxayna u beddeshaa daawo kasta, oo ay ku jiraan tallaalada, unugyada yaryar iyo kuwa waaweyn, iyo bayoolojiga, budo qallalan oo quruxsan oo si fudud loo nuugi karo oo si fiican u nuugaya, markaa daawadu sidoo kale waa la heli karaa. geeyey.indhaha, sanka iyo maqaarka deegaanka.TFF waxay leedahay laba musharrax oo waaweyn oo dawooyinka kiliinikada ah, budada neefsashada ee voriconazole iyo budada neefsashada tacrolimus, waxayna sii waddaa ballaarinta faylalka si ay u beddesho daryeelka caafimaadka caalamiga ah iyada oo la kaashanaysa shirkado badan oo dawooyinka, machadyada tacliinta iyo la-hawlgalayaasha dawladda.Madal TFF waxa daboolay in ka badan 120 shatiyo laga soo saaray ama laga sugayo Maraykanka iyo dalalka kale.Si aad wax badan uga barato TFF Pharmaceuticals iyo alaabteeda musharraxiinta, fadlan booqo bogga shirkadda ee https://tffpharma.com.
Safe Harbor War-saxaafadeedkani waxa uu ka kooban yahay odhaaho horudhac u ah oo ku saabsan TFF Pharmaceuticals, Inc., oo ay ku jiraan rajooyinka laga filayo horumarinta joogtada ah ee tacrolimus iyo voriconazole ee budada la nuugo, faa'iidooyinka TFF ee shirkadda, iyo qorshayaasha shirkadu inay ku darto khadadka alaabta musharax ee hadda jira. .Odhaahyadan mustaqbalka fogi waxay ku lug leeyihiin khataro la yaqaan iyo kuwo aan la garanayn, hubanti la'aan iyo arrimo kale oo keeni kara in natiijooyinka dhabta ahi ay kala duwanaadaan.Qodobbadaan waxaa ka mid ah: (i) khatarta ah in shirkadu aysan awoodi doonin inay si guul leh u dhamaystirto tijaabooyinka bukaan-socodka ama u hesho ogolaansho horudhac ah oo loogu talagalay tacrolimus la nuugo, budada voriconazole, ama mid ka mid ah musharaxiinta budada qalalan, (ii) la'aanta liiska dawada TFF waxay heshay ogolaanshaha FDA ka hor ama haddii kale liiska dawooyinka ganacsiga, (iii) shirkadu hadda heshiis ama isfaham lama lahan shirkado waaweyn oo dawooyinka si ay u soo saaraan dawo loogu daro madal TFF, (iv) shirkadu ma awoodi doonto inay heshiisyo ganacsi oo wakhti dheer ah la gasho cid saddexaad;iyo (v) khataraha kale ee lagu sheegay qaybta “Arimaha Khatarta” ee Foomka 10 ee Warbixinta Sannadlaha ah ee shirkadda 2021 – K, oo lagu xareeyay SEC Maarso 24, 2022. Daawooyinka TFF waxa ay uga digaysaa akhristayaasha in aanay ku tiirsanaan aan munaasib ahayn midna ama horayba- hadallo eegaya.Pharmaceuticals TFF waxay qaadataa oo si gaar ah u diidaya waajibaad kasta oo ah in la cusboonaysiiyo ama dib-u-eegis lagu sameeyo weedhahan si ay uga tarjumaan duruufo cusub ama xaalado lama filaan ah, marka laga reebo sida uu sharcigu farayo.
TFF Pharmaceuticals Investor Relations Contact: Corey Davis, PhD LifeSci Advisorsscdavis@lifesciadvisors.com 212-915-2577
TFF Pharmaceuticals Media Contact: Gwendolyn SchankerLifeSci Communications(269) 921-3607gschanker@lifescicomms.com
Waqtiga boostada: Agoosto-10-2022